copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
MedImmune - Wikipedia MedImmune conducted successful clinical trials for a new generation of FluMist needle-free vaccine, called CAIV-T, which was approved by the U S Food and Drug Administration (FDA) in 2007, and is now the form offered on the market
MedImmune - LinkedIn MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines
MedImmune - AstraZeneca MedImmune is progressing a next generation, extended half-life mAb for RSV Target • Novel, neutralizing epitope on the RSV F protein, located on the surface of the virion
AstraZeneca retires Medimmune name amid sales turnaround After 30 years of drug development, MedImmune will cease to exist as an industry name now that owner AstraZeneca has decided to retire the brand as part of ongoing restructuring efforts
MedImmune, Inc. -- Company History MedImmune is a fully integrated biopharmaceutical company focused on developing and marketing products that address medical needs in areas such as infectious disease, immune regulation and cancer
MedImmune - 2025 Company Profile Team - Tracxn MedImmune is an acquired company based in Gaithersburg (United States), founded in 1987 It operates as a Biologic R D for oncology; respiratory, inflammation and autoimmune; and cardiovascular and metabolic diseases
MedImmune (biologics division of AstraZeneca) - [LSUS] Life-Sciences . . . MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines
MedImmune – Bethesda Green The Gaithersburg campus led the way in energy conservation and carbon emissions reduction at MedImmune and AstraZeneca In 2010, we pledged to reduce our energy intensity by 25% by 2020 through the US Department of Energy’s (DOE) Better Plants® program, and are currently on target to meet that goal